Nysom, K., Kilburn, L. B., Leary, S. E. S., Landi, D. B., de Vos-Kerkhof, E., Perreault, S., . . . Hargrave, D. R. (2024). Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial. Neuro-Oncology, 27(5), . https://doi.org/10.1093/neuonc/noae274
Chicago-Zitierstil (17. Ausg.)Nysom, Karsten, et al. "Radiographic and Visual Response to the Type II RAF Inhibitor Tovorafenib in Children with Relapsed/refractory Optic Pathway Glioma in the FIREFLY-1 Trial." Neuro-Oncology 27, no. 5 (2024). https://doi.org/10.1093/neuonc/noae274.
MLA-Zitierstil (9. Ausg.)Nysom, Karsten, et al. "Radiographic and Visual Response to the Type II RAF Inhibitor Tovorafenib in Children with Relapsed/refractory Optic Pathway Glioma in the FIREFLY-1 Trial." Neuro-Oncology, vol. 27, no. 5, 2024, https://doi.org/10.1093/neuonc/noae274.